Get started
Author

Ákos Gulybán

Observed names: A Gulyban, A. Gulyban, Akos GULYBAN, Akos Gulyban, Akos Gulybán, GULYBAN, Akos, Gulyban, Akos, Gulybán, Ákos, Á. Gulybán
Observed institutions: European Organisation for Research and Treatment of Cancer, Université Libre de Bruxelles, Shandong University, University of Liège, University of Szeged, Tata Memorial Hospital, Ghent University Hospital, Institut Jules Bordet, The Netherlands Cancer Institute, Europe Hospitals, Shandong Tumor Hospital, European Organisation for Research and Treatment of Cancer, Universitair Ziekenhuis Brussel, Centre Hospitalier Régional Universitaire de Brest, Centre Hospitalier Universitaire de Liège, Centre Hospitalier Universitaire de Saint-Pierre, University of Pecs
ORCID: 0000-0002-6805-8802
Observed ORCID: 0000-0002-6805-8802
OpenAlex ID: A5045164379
EORTC-ROG expert opinion: Radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach
2009 · Oscar Matzinger, Erich Gerber, et al. · Radiotherapy and Oncology · 141
Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925)
2010 · Oscar Matzinger, Irma Heimsoth, et al. · Acta Oncologica · 120
PDF
Interobserver variability in delineation of target volumes in head and neck cancer
2019 · Julie van der Veen, Akos Gulyban, et al. · Radiotherapy and Oncology · 118
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991
2009 · O. Matzinger, F. Duclos, et al. · European Journal of Cancer · 98
Quality assurance for prospective EORTC radiation oncology trials: The challenges of advanced technology in a multicenter international setting
2011 · Damien C. Weber, Philip M.P. Poortmans, et al. · Radiotherapy and Oncology · 95
Interobserver variability in organ at risk delineation in head and neck cancer
2021 · J. van der Veen, A. Gulyban, et al. · Radiation Oncology · 88
PDF
Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: Dummy run and individual case review
2008 · Oscar Matzinger, Philip Poortmans, et al. · Radiotherapy and Oncology · 60
Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?
2015 · Patrick Berkovic, Leen Paelinck, et al. · Acta Oncologica · 50
PDF
Improving generalization in MR‐to‐CT synthesis in radiotherapy by using an augmented cycle generative adversarial network with unpaired data
2021 · Kévin N. D. Brou Boni, John Klein, et al. · Medical Physics · 48
PDF
Quality assurance in the EORTC 22033–26033/CE5 phase III randomized trial for low grade glioma: The digital individual case review
2012 · Alysa Fairchild, Damien C. Weber, et al. · Radiotherapy and Oncology · 45
EORTC Radiation Oncology Group quality assurance platform: Establishment of a digital central review facility
2012 · Alysa Fairchild, Edwin Aird, et al. · Radiotherapy and Oncology · 39
Multisegmented Tangential Breast Fields: a Rational Way to Treat Breast Cancer
2008 · Ákos Gulybán, Péter Kovács, et al. · Strahlentherapie und Onkologie · 39
Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials?
2012 · A. Fairchild, L. Collette, et al. · European Journal of Cancer · 38
PDF
Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience
2015 · Ferenc Lakosi, Marjoelin de Cuypere, et al. · Acta Oncologica · 36
PDF
Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial
2017 · Leen Paelinck, Akos Gulyban, et al. · Radiotherapy and Oncology · 30
PDF
Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning
2010 · Elena Musat, Erik Roelofs, et al. · Radiotherapy and Oncology · 29
Setup accuracy for prone and supine whole breast irradiation
2016 · Thomas Mulliez, Akos Gulyban, et al. · Strahlentherapie und Onkologie · 24
Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: Results of the Dummy Run procedure
2013 · Paul A. Fenton, Coen Hurkmans, et al. · Radiotherapy and Oncology · 24
Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases
2020 · Patrick Berkovic, Akos Gulyban, et al. · BMC Cancer · 23
PDF
Triggered Imaging With Auto Beam Hold and Pre-/Posttreatment CBCT During Prostate SABR: Analysis of Time Efficiency, Target Coverage, and Normal Volume Changes
2020 · Katalin Kisivan, Gergely Antal, et al. · Practical Radiation Oncology · 21
Respiratory Motion, Anterior Heart Displacement and Heart Dosimetry: Comparison Between Prone (Pr) and Supine (Su) Whole Breast Irradiation
2015 · Ferenc Lakosi, Akos Gulyban, et al. · Pathology & Oncology Research · 21
Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values
2022 · Zelda Paquier, Shih-Li Chao, et al. · Biomedical Physics & Engineering Express · 20
PDF
A simple clinical method for predicting the benefit of prone vs. supine positioning in reducing heart exposure during left breast radiotherapy
2018 · Zsuzsanna Kahán, Ferenc Rárosi, et al. · Radiotherapy and Oncology · 20
PDF
Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction
2017 · Patrick Berkovic, Leen Paelinck, et al. · Acta Oncologica · 20
PDF
Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence
2017 · Patrick Berkovic, Akos Gulyban, et al. · Clinical Colorectal Cancer · 20
PDF
Works count: 170
Citation count: 1,508
H-index: 21
I10-index: 35
Year
Topic
Type